Meta-analysis of Gene Expression Profiles Indicates Genes in Spliceosome Pathway Are Up-regulated in Hepatocellular Carcinoma (HCC)

Overview

Journal Med Oncol

Publisher Springer

Specialty Oncology

Date 2015 Mar 4

PMID 25731616

Citations 44

Authors

Weijin Xu

Huixing Huang

Long Yu

Lihuan Cao

Affiliations

Soon will be listed here.

Abstract

Hepatocellular carcinoma (HCC) is among the commonest kind of malignant tumors, which accounts for more than 500,000 cases of newly diagnosed cancer annually. Many microarray studies for identifying differentially expressed genes (DEGs) in HCC have been conducted, but results have varied across different studies. Here, we performed a meta-analysis of publicly available microarray Gene Expression Omnibus datasets, which covers five independent studies, containing 753 HCC samples and 638 non-tumor liver samples. We identified 192 DEGs that were consistently up-regulated in HCC vs. normal liver tissue. For the 192 up-regulated genes, we performed Kyoto Encyclopedia of Genes and Genomes pathway analysis. To our surprise, besides several cell growth-related pathways, spliceosome pathway was also up-regulated in HCC. For further exploring the relationship between spliceosome pathway and HCC, we investigated the expression data of spliceosome pathway genes in 15 independent studies in Nextbio database ( https://www.nextbio.com/b/nextbioCorp.nb ). It was found that many genes of spliceosome pathway such as HSPA1A, SNRPE, SF3B2, SF3B4 and TRA2A genes which we identified to be up-regulated in our meta-analysis were generally overexpressed in HCC. At last, using real-time PCR, we also found that BUD31, SF3B2, SF3B4, SNRPE, SPINK1, TPA2A and HSPA1A genes are significantly up-regulated in clinical HCC samples when compared to the corresponding non-tumorous liver tissues. Our study for the first time indicates that many genes of spliceosome pathway are up-regulated in HCC. This finding might put new insights for people's understanding about the relationship of spliceosome pathway and HCC.

Citing Articles

Oncofetal SNRPE promotes HCC tumorigenesis by regulating the FGFR4 expression through alternative splicing.

Wu Q, Liao R, Miao C, Hasnat M, Li L, Sun L Br J Cancer. 2024; 131(1):77-89.

PMID: 38796598 PMC: 11231362. DOI: 10.1038/s41416-024-02689-5.

The role of alternative pre-mRNA splicing in cancer progression.

Choi S, Cho N, Kim E, Kim K Cancer Cell Int. 2023; 23(1):249.

PMID: 37875914 PMC: 10594706. DOI: 10.1186/s12935-023-03094-3.

PPIH gene regulation system and its prognostic significance in hepatocellular carcinoma: a comprehensive analysis.

Ye J, Pang Y, Yang X, Zhang C, Shi L, Chen Z Aging (Albany NY). 2023; 15(20):11448-11470.

PMID: 37874737 PMC: 10637785. DOI: 10.18632/aging.205134.

USP39 promotes hepatocellular carcinogenesis through regulating alternative splicing in cooperation with SRSF6/HNRNPC.

Zheng J, Wu S, Tang M, Xi S, Wang Y, Ren J Cell Death Dis. 2023; 14(10):670.

PMID: 37821439 PMC: 10567755. DOI: 10.1038/s41419-023-06210-3.

MKRN1 promotes colorectal cancer metastasis by activating the TGF-β signalling pathway through SNIP1 protein degradation.

Zhang Y, Li Q, Liu H, Tang H, Yang H, Wu D J Exp Clin Cancer Res. 2023; 42(1):219.

PMID: 37620897 PMC: 10464235. DOI: 10.1186/s13046-023-02788-w.

References

Gabriel B, Zur Hausen A, Bouda J, Boudova L, Koprivova M, Hirschfeld M . Significance of nuclear hTra2-beta1 expression in cervical cancer. Acta Obstet Gynecol Scand. 2008; 88(2):216-21. DOI: 10.1080/00016340802503021. View

Modrek B, Lee C . A genomic view of alternative splicing. Nat Genet. 2001; 30(1):13-9. DOI: 10.1038/ng0102-13. View

Zaravinos A, Lambrou G, Boulalas I, Delakas D, Spandidos D . Identification of common differentially expressed genes in urinary bladder cancer. PLoS One. 2011; 6(4):e18135. PMC: 3070717. DOI: 10.1371/journal.pone.0018135. View

Kanehisa M, Goto S . KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 1999; 28(1):27-30. PMC: 102409. DOI: 10.1093/nar/28.1.27. View

Kupershmidt I, Su Q, Grewal A, Sundaresh S, Halperin I, Flynn J . Ontology-based meta-analysis of global collections of high-throughput public data. PLoS One. 2010; 5(9). PMC: 2947508. DOI: 10.1371/journal.pone.0013066. View

Best A, Dagliesh C, Ehrmann I, Kheirollahi-Kouhestani M, Tyson-Capper A, Elliott D . Expression of Tra2 β in Cancer Cells as a Potential Contributory Factor to Neoplasia and Metastasis. Int J Cell Biol. 2013; 2013:843781. PMC: 3723085. DOI: 10.1155/2013/843781. View

Barash Y, Calarco J, Gao W, Pan Q, Wang X, Shai O . Deciphering the splicing code. Nature. 2010; 465(7294):53-9. DOI: 10.1038/nature09000. View

Nilsen T . The spliceosome: the most complex macromolecular machine in the cell?. Bioessays. 2003; 25(12):1147-9. DOI: 10.1002/bies.10394. View

Tung E, Mak C, Fatima S, Lo R, Zhao H, Zhang C . Clinicopathological and prognostic significance of serum and tissue Dickkopf-1 levels in human hepatocellular carcinoma. Liver Int. 2011; 31(10):1494-504. DOI: 10.1111/j.1478-3231.2011.02597.x. View

10.

Wurmbach E, Chen Y, Khitrov G, Zhang W, Roayaie S, Schwartz M . Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology. 2007; 45(4):938-47. DOI: 10.1002/hep.21622. View

11.

Sung W, Zheng H, Li S, Chen R, Liu X, Li Y . Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet. 2012; 44(7):765-9. DOI: 10.1038/ng.2295. View

12.

Chen C, Fu X, Zhang D, Li Y, Xie Y, Li Y . Varied pathways of stage IA lung adenocarcinomas discovered by integrated gene expression analysis. Int J Biol Sci. 2011; 7(5):551-66. PMC: 3088877. DOI: 10.7150/ijbs.7.551. View

13.

Dehm S . Test-firing ammunition for spliceosome inhibition in cancer. Clin Cancer Res. 2013; 19(22):6064-6. PMC: 3839097. DOI: 10.1158/1078-0432.CCR-13-2461. View

14.

Law P, Ching A, Chan A, Wong Q, Wong C, To K . MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma. Carcinogenesis. 2012; 33(6):1134-41. DOI: 10.1093/carcin/bgs130. View

15.

Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang C, Angelo M . Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci U S A. 2001; 98(26):15149-54. PMC: 64998. DOI: 10.1073/pnas.211566398. View

16.

Roessler S, Jia H, Budhu A, Forgues M, Ye Q, Lee J . A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res. 2010; 70(24):10202-12. PMC: 3064515. DOI: 10.1158/0008-5472.CAN-10-2607. View

17.

Voglauer R, Chang M, Dampier B, Wieser M, Baumann K, Sterovsky T . SNEV overexpression extends the life span of human endothelial cells. Exp Cell Res. 2006; 312(6):746-59. DOI: 10.1016/j.yexcr.2005.11.025. View

18.

Neklason D, Solomon C, Dalton A, Kuwada S, Burt R . Intron 4 mutation in APC gene results in splice defect and attenuated FAP phenotype. Fam Cancer. 2004; 3(1):35-40. DOI: 10.1023/B:FAME.0000026824.85766.22. View

19.

Wahl M, Will C, Luhrmann R . The spliceosome: design principles of a dynamic RNP machine. Cell. 2009; 136(4):701-18. DOI: 10.1016/j.cell.2009.02.009. View

20.

Huang D, Sherman B, Lempicki R . Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2008; 37(1):1-13. PMC: 2615629. DOI: 10.1093/nar/gkn923. View